Trending

Liquidia Technologies undertakes Phase 3 Clinical Trial of LIQ861 for Diagnosing PAH

Read more

PPD appoints Colin Hill to its Board of Directors

Read more

ANI Pharmaceuticals acquires four NDAs from AstraZeneca for $46.5 Million

Read more

I-Mab Biopharma signs licensing agreement for HyLeukin with Genexine

Read more

Mallinckrodt to acquire Sucampo Pharmaceuticals for approximately $1.2 Billion

Read more

Teva Announces Exclusive Launch of a Generic Version of Reyataz in the U.S.

Read more

Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis

Read more